# Hua Medicine (Shanghai)

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hua-medicine-shanghai

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.huamedicine.com
- Total disclosed funding: $75M
- Latest round: Series D (Mar 26, 2018)
- Investors on record: 16

## About

Founded in 2010 and based in Shanghai, China, Hua Medicine (Shanghai) Ltd. is a biopharmaceutical company that focuses on developing medical drugs for the treatment of diabetes.

## Funding rounds

- Series D, Mar 26, 2018 — ARCH Venture Partners, GIC, Venrock, Eight Roads Ventures, F-Prime Capital, Ping An Trust, Ally Bridge Group, 6 Dimensions Capital, Blue Pool Capital, China Harvest Investments, Mirae Asset Management, 6 Dimensions Capital, AVICT Global Holdings
- Series C, Apr 22, 2016, $50M — ARCH Venture Partners, SAIL Capital Partners, Venrock, Eight Roads Ventures, F-Prime Capital, Frontline BioVentures, Ally Bridge Group, Wuxi Huading Venture Capital, TF Capital, China Harvest Investments
- Series B, Jan 8, 2015, $25M — ARCH Venture Partners, SAIL Capital Partners, Venrock, Eight Roads Ventures, F-Prime Capital, Frontline BioVentures, Ally Bridge Group, 6 Dimensions Capital, TF Capital

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series B, Series C, Series D
- SAIL Capital Partners (https://capitalatlas.ai/funds/sail-capital-partners) — Series B, Series C
- Venrock (https://capitalatlas.ai/funds/venrock) — Series B, Series C, Series D
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series B, Series C, Series D
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series B, Series C, Series D
- Frontline BioVentures (https://capitalatlas.ai/funds/frontline-bioventures) — Series B, Series C
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series B, Series C, Series D
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series B, Series D
- TF Capital — Series B, Series C
- Wuxi Huading Venture Capital (https://capitalatlas.ai/funds/wuxi-huading-venture-capital) — Series C
- China Harvest Investments — Series C, Series D
- GIC — Series D
- Ping An Trust — Series D
- Blue Pool Capital (https://capitalatlas.ai/funds/blue-pool-capital) — Series D
- Mirae Asset Management — Series D
- AVICT Global Holdings — Series D